Literature DB >> 34657267

Effect of vitamin D supplementation on OPG/RANKL signalling activities in endothelial tissue damage in diet-induced diabetic rat model.

Gizem Celebi1,2,3, Merve Anapali4,5, Fatma Kaya Dagistanli4, Ayse Seda Akdemir4, Duygu Aydemir6,7, Nuriye Nuray Ulusu6,7, Turgut Ulutin4, Evrim Komurcu-Bayrak8,9.   

Abstract

BACKGROUND: Type 2 Diabetes Mellitus is a chronic metabolic disease that causes endothelial damage and is an important risk factor for atherosclerosis. In the present study vitamin D3 supplementation in rats was used to determine the role of Osteoprotegerin (OPG)/Receptor activator kB ligand (RANKL) signalling in endothelial damage and changes in the expression levels of genes involved in this pathway. We hypothesized that vitamin D3 supplementation affects OPG and RANKL activity in the aorta.
METHODS: Diabetes was induced in rats via injections of 40 mg/kg of streptozotocin followed by a high fructose (10%) diet. Group 2 (healthy) and 4 (diabetic) received 170 IU/kg of vitamin D3 weekly for 5 weeks, while Group 1 (healthy) and 2 (diabetic) received sterile saline. The aortas of each group were collected to analyse mRNA expression using the real-time PCR method and also to evaluate magnesium and calcium levels using inductively coupled plasma mass spectrometry.
RESULTS: Opg and Il-1b expression levels were significantly associated with both diabetes and vitamin D3 supplementation in the aortas of the study groups (p ≤ 0.05). Opg mRNA expression was also found to correlate with both Icam-1 and Nos3 mRNA expression levels (r = 0.699, p = 0.001 and r = 0.622, p = 0.003, respectively). In addition, when mineral levels in the aortic tissues were compared among all groups, it was found that the interaction of diabetes and vitamin D3 supplementation significantly affected Mg levels and Mg/Ca ratios.
CONCLUSIONS: It is concluded that vitamin D3 supplementation has a modulatory effect on OPG/RANKL activity in the vessel wall by ameliorating endothelial damage in diabetes. This effect may contribute to the regulation of cytokine-mediated vascular homeostasis and mineral deposition in the aorta; therefore, further comprehensive studies are proposed to demonstrate this relationship.
© 2021. Maj Institute of Pharmacology Polish Academy of Sciences.

Entities:  

Keywords:  Diabetes; Endothelial damage; OPG; RANKL; Vitamin D3

Mesh:

Substances:

Year:  2021        PMID: 34657267     DOI: 10.1007/s43440-021-00332-1

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  57 in total

1.  [Association between osteoporosis and atherosclerosis in dyslipidemia.]

Authors:  Nobuyuki Tai; Daisuke Inoue
Journal:  Clin Calcium       Date:  2019

2.  Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.

Authors:  I Barchetta; V Ceccarelli; F A Cimini; L Bertoccini; A Fraioli; C Alessandri; A Lenzi; M G Baroni; M G Cavallo
Journal:  J Endocrinol Invest       Date:  2018-08-21       Impact factor: 4.256

Review 3.  Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.

Authors:  Benjamin M Leon; Thomas M Maddox
Journal:  World J Diabetes       Date:  2015-10-10

4.  Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.

Authors:  Luis F de Castro; Andrea B Burke; Howard D Wang; Jeffrey Tsai; Pablo Florenzano; Kristen S Pan; Nisan Bhattacharyya; Alison M Boyce; Rachel I Gafni; Alfredo A Molinolo; Pamela G Robey; Michael T Collins
Journal:  J Bone Miner Res       Date:  2018-11-29       Impact factor: 6.741

Review 5.  Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.

Authors:  Sandra J Hamilton; Gerald F Watts
Journal:  Rev Diabet Stud       Date:  2013-08-10

Review 6.  The Emerging Role of Bone Markers in Diagnosis and Risk Stratification of Patients With Coronary Artery Disease.

Authors:  Marinos Kosmopoulos; Stavroula A Paschou; Julia Grapsa; Panagiotis Anagnostis; Andromachi Vryonidou; Dimitrios G Goulis; Gerasimos Siasos
Journal:  Angiology       Date:  2019-01-29       Impact factor: 3.619

7.  Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.

Authors:  Brian J Bennett; Marta Scatena; Elizabeth A Kirk; Marcello Rattazzi; Rebecca M Varon; Michelle Averill; Stephen M Schwartz; Cecilia M Giachelli; Michael E Rosenfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-07-13       Impact factor: 8.311

8.  Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.

Authors:  Joseph S McGonigle; Cecilia M Giachelli; Marta Scatena
Journal:  Angiogenesis       Date:  2008-12-23       Impact factor: 9.596

Review 9.  Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.

Authors:  Hadi A R Hadi; Cornelia S Carr; Jassim Al Suwaidi
Journal:  Vasc Health Risk Manag       Date:  2005

10.  Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients.

Authors:  Mahmoud A Alfaqih; Nabil Bashir; Rami Saadeh; Yousef Khader; Musa Barqawi; Sara Alqudah
Journal:  BMC Res Notes       Date:  2018-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.